Empirica Therapeutics, a startup co-founded by Donnelly Centre investigatorJason Moffathas beenacquired by Century Therapeutics, a U.S. based company developing off-the-shelf cell therapy products for cancer. Century will develop Empiricas proof-of-principle treatment for glioblastoma, an aggressive form of brain cancer, into therapy that can be tested on patients.
Recent Comments